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Abstract: Despite the large efforts to prepare super paramagnetic iron oxide nanoparticles 
(MNPs) for biomedical applications, the number of FDA or EMA approved formulations is 
few. It is not known commonly that the approved formulations in many instances have 
already been withdrawn or discontinued by the producers; at present, hardly any approved 
formulations are produced and marketed. Literature survey reveals that there is a lack for a 
commonly accepted physicochemical practice in designing and qualifying formulations 
before they enter in vitro and in vivo biological testing. Such a standard procedure would 
exclude inadequate formulations from clinical trials thus improving their outcome. Here we 
OPEN ACCESS
Int. J. Mol. Sci. 2013, 14 14551 
 
 
present a straightforward route to assess eligibility of carboxylated MNPs for biomedical 
tests applied for a series of our core-shell products, i.e., citric acid, gallic acid, poly(acrylic 
acid) and poly(acrylic acid-co-maleic acid) coated MNPs. The discussion is based on 
physicochemical studies (carboxylate adsorption/desorption, FTIR-ATR, iron dissolution, 
zeta potential, particle size, coagulation kinetics and magnetization measurements) and 
involves in vitro and in vivo tests. Our procedure can serve as an example to construct 
adequate physico-chemical selection strategies for preparation of other types of core-shell 
nanoparticles as well.  
Keywords: carboxylated magnetite nanoparticles; core-shell nanoparticles; adsorption; 
surface complexation; chemical stability; iron dissolution; colloidal stability; particle 
charge; biocompatibility; biomedical application 
 
1. Introduction 
Nanobiotechnology can be applied to produce nanosized and/or nanostructured drug formulations 
for diagnostics, therapy or theranostics. The state-of-the-art of nanobiotechnology is promising [1–8]; 
but there is a gap between the ideas and the realizations [9]. Basic nanoscience research could not be 
converted into clinically verified and marketed medical products at a considerable scale as it is shown 
in a recent review by Etheridge et al. [10]. This is especially true of iron oxide nanoparticles 
(superparamagnetic iron oxide—SPIO, ultra small superparamagnetic iron oxide—USPIO or 
magnetite nanoparticles—MNPs), for which 66 clinical trials have been initiated [10], but only a few 
approved formulations can be found in databases such as FDA (U S Food and Drug Administration) or 
EMA (European Medicines Agency). In addition, the most of them have subsequently been discontinued 
or withdrawn by the producers. Some examples are Ferumoxides (Feridex I.V., Endorem) [11], 
Ferumoxsil [12] and Ferumoxtran-10 (Sinerem—Withdrawn from EMA [13]; Combidex—Not yet 
approved by FDA) [14]). We could identify only one approved and used formulation, Ferumoxytol 
(Feraheme), but it is approved for treating iron deficiency and thus, iron release from the nanoparticles 
is expected a priori [15]. One commonly referred formulation VSOP C-184 completed only the first 
phase clinical trial (2006) and another one, Ferucarbotran (Resovist), the third phase (2003); these are 
not yet approved [16,17]. Etheridge et al. [10] noted that “…academic, government, and industry 
experts did not expect to see “nanomachines” capable of theranostics (combined therapy and 
diagnostics) in human beings until 2025”. One of the many reasons for the inefficient progress in 
medical implementation can be connected with the absence of an appropriate physicochemical testing 
of the particles. The majority of research studies do not even provide experimental evidence whether 
an optimization process has been used in designing the given composition. Adequate physicochemical 
qualification of both the formulation procedure and the end products is inevitable for improving 
nanoparticle performance and reproducibility. Dufort and co-authors [18] attempted to specify the 
types of in vitro nanoparticle evaluation methods that should be performed prior to in vivo tests and 
highlighted the importance of physicochemical experiments in predicting the fate of nanoparticles  
in vivo. However, the latter had not been classified as a separate group of the in vitro experiments. 
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The procedure of core-shell nanoparticle preparation affects the biological performance of the  
end-products. The preparation method of the naked MNPs determines their physical properties such as 
particle size, shape and magnetization [19]. As it is demonstrated, for example, in the work of Rinaldi 
and co-authors [20], covalent anchoring in many instances can enhance colloidal stability as compared 
with the physico-chemical adsorption of coating molecules. If a chemical surface modification method 
is used, however, all the applied chemicals and byproducts should be removed in order to reduce the 
chemical hazard of the formulation. MNPs designed for cellular uptake should be coated by a 
negatively charged shell and an uncharged shell is needed for avoiding cellular uptake [21]. Specific 
labeling or drug-loading of core-shell MNPs can alter the particle-particle interactions i.e., affect 
dispersion stability, which should also be considered during preparation.  
In the present paper, we attempt to set up a useful methodology of physicochemical testing of  
core-shell magnetite nanoparticles. Since the different procedures of core-shell MNP preparation 
require specific methodologies, we discuss only the process of coating via adsorption of small and 
macromolecular carboxylates and rely on our own experience [22–26]. 
Independent of their specific biological functionality, all the MNP formulations must retain their 
chemical and colloidal stability in vivo under the applied magnetic field. It is known that the naked 
MNPs are both chemically and colloidally unstable in biological fluids even in the absence of magnetic 
field. Coating shells of proper structure can render them chemically stable via passivation of the 
magnetic core [27] and provide enhanced colloidal stability by way of increasing electrostatic and/or steric 
repulsion between the MNPs. The optimization of the carboxylated coatings on magnetite nanoparticles 
presented in this paper can be adapted to prepare other types of coated nanoparticles as well.  
Our protocol of coated MNP preparation eligible for in vitro and in vivo experiments consists of  
six basic steps of measuring (i) carboxylate adsorption; (ii) dilution resistance of the adsorbed layer; 
(iii) iron dissolution; (iv) electrokinetic potential; (v) particle size; and (vi) salt tolerance. We 
demonstrate the procedure through the examples of citric acid, gallic acid, poly(acrylic acid), and 
poly(acrylic acid-co-maleic acid) coated MNPs (CA@MNP, GA@MNP, PAA@MNP and 
PAM@MNP, respectively) [22–26]. The results of coating the MNPs with GA, PAA and PAM are 
published in detail and new experiments for CA-coating are added to the discussion here because of 
the definite popularity of citric acid as MNP surface modifier in both literature and clinical trials. The 
experiments listed above give a comprehensive colloidal characterization of carboxylate@MNPs. We 
note that iron dissolution experiments are inevitable in this case to prove the chemical stability of the 
MNP core. It is well known that the presence of dissolved ferric ion can cause oxidative stress [28], 
and it has been also shown that dissolved iron leads to cellular damage [29]. The performance of our 
optimized carboxylate@MNPs was tested in vitro in cytotoxicity, blood sedimentation and blood 
aggregation experiments, and in vivo after intravenous (IV) injection in rat tail. The dissolution and 
distribution of particles in the cellular environment and rat tail tissue are shown in this paper.  
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2. Results and Discussion 
2.1. The Strength of Core-Shell Binding  
The strength of core-shell binding determines the long-term persistency of nanocomposites. We 
have measured adsorption and desorption isotherms to evaluate binding affinity and dilution resistance 
of the coatings. In addition, FTIR-ATR spectra were taken to identify the bonds of the carboxylate and 
alcohol moieties of the carboxylates to the MNP surface.  
2.1.1. Adsorption and Desorption of the Carboxylates 
The results of the adsorption and desorption measurements performed at pH ~6 and at I = 0.01 M 
are seen in Figure 1.  
Figure 1. Adsorption isotherms of CA, GA, PAA, and PAM (a) and adsorption (─) and 
desorption (----) isotherms of PAA (∆) and PAM (o) (b) on MNP measured at pH ~6 and  
I = 0.01 M. The lines are drawn to guide the eyes. The error bars in (a) are omitted for clarity. 
 
The pH and ionic strength were chosen so as to optimize the electrostatic conditions for the 
adsorption interaction. As it is discussed in detail [23,24], the carboxylates are negatively and the 
MNPs positively charged at the selected values of pH and ionic strength, with maximized electrostatic 
attraction between them; a shift in the pH or an increase in the ionic strength would decrease the 
attraction. The molar amounts of carboxylate groups were chosen to calculate the adsorption/desorption 
isotherms, because they have primary importance in the electrostatic stabilization. The main features of 
the isotherms can be best discussed using the Giles classification [30]. H (high-affinity)-type isotherms 
were obtained for CA, GA and PAM, and L (Langmuir)-type isotherm for PAA. The high-affinity 
limit was ~0.3 mmol/g for CA and PAM, ~0.15 mmol/g for GA, and 0 mmol/g (i.e., there was no high 
affinity observed) for PAA. The high affinity limits express the amounts of carboxylates bound 
practically irreversibly (with an extremely high residence time in the adsorbed layer and a negligible 
concentration in the dispersion medium). Based on these values, the preference for coating shell formation 
decreases in the order CA ~ PAM > GA > PAA. The maximum adsorbed amounts of the carboxylates seen 
as the plateau values of the isotherms vary significantly. Definite values of ~0.9 mmol/g and ~0.6 mmol/g 
are revealed for PAM and PAA. For CA and GA, however, plateau regions cannot be identified. 
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Instead, a linearly increasing part is obtained in both cases, not characteristic of common adsorption 
isotherms. These isotherms represent the combined process of adsorption and surface  
polymerization [25,26]. Regarding the maximum of adsorption, PAM is more preferable for shell 
formation than PAA, because the higher adsorbed amount of carboxylates implies a thicker coating 
shell. The much lower equilibrium carboxylate concentration at the plateau of PAM adsorption  
(~1 mmol/L for PAM versus ~4 mmol/L for PAA) also makes it preferable. The amount of free 
carboxylates in the medium of MNP formulations should be minimal, because of their possible 
undesirable effects; this is best achieved by keeping their concentration as low as possible during the 
preparation. In Figure 1b, the isotherms of desorption are plotted together with that of adsorption. The 
desorption curves run above the adsorption ones for both PAM and PAA suggesting that both coatings 
are in principle dilution resistant within the time frame of our experiment. We did not attempt 
measuring desorption of CA and GA because their adsorption is superimposed by surface 
polymerization making desorption experiments irrelevant. It has been shown for a series of core-shell 
MNPs [31,32] that shells can be displaced by adsorption of phosphate from biological buffers 
depending on the size and the anchoring type of coating molecule and the density of coating. Samples 
resisting shell detachment in aqueous NaCl solutions should be subject to tests in PBS and different 
cell culture media in further in vitro studies.  
The adsorption of small molecular or polymeric carboxylates is a widely applied method of  
core-shell MNP preparation, but the isotherms are rarely measured and analyzed. However, the 
information extracted from these is inevitable for synthesis design. On the basis of the above discussed 
isotherm characteristics and parameters, the candidates for coating MNPs can be qualified with respect 
to the bond strength, dilution resistance and shell compactness. Therefore, high-affinity character, high 
adsorption density and low equilibrium concentration are expected as the main selection criteria. 
2.1.2. Molecular Mechanism of the Carboxylate-MNP Surface Interactions 
Core-shell binding quality was tested by surface spectroscopy. The shifts in the characteristic IR 
frequencies of the –COOH groups were used to detect the type of binding to the MNP surface.  
The absorption spectra of GA, PAA and PAM coated MNP samples have been published  
previously [23,24,26] and that of CA@MNP and pure CA are seen in Figure 2. Due to CA adsorption, 
the symmetric and asymmetric stretching vibrations of the –COO− groups (dissociated carboxylates, at 
the pH of the formulation) shifted from 1387 cm−1 and 1562 cm−1 (pure CA) to 1396 cm−1 and  
1620 cm−1 (CA@MNP) with Δνsym,COO− = 9 cm−1 and Δνasym,COO− = 58 cm−1, respectively. This 
indicates inner sphere Fe-carboxylate complex formation. The same was observed for PAM adsorption 
with frequency changes of Δsym,COO− = 4 cm−1 and Δasym,COO− = 7 cm−1. On the contrary, carboxylate 
frequencies did not shift to higher values in PAA and GA adsorption; in fact the νsym,COO− of GA even 
shifted to lower frequency (Δνsym,COO− = −11 cm−1). These results imply that the –COO− groups are not 
involved in the adsorption of PAA and GA. H-bonding between ≡Fe–OH and non-dissociated –COOH 
groups (i.e., outer-sphere surface complex formation) was identified as the main adsorption mechanism 
for PAA and direct Fe–O–C– bonding with phenolic OH– groups (i.e., inner-sphere surface complex 
formation) for GA adsorption. 
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Figure 2. FTIR-ATR spectra of pure CA (---) and CA@MNP at 0.25 mmol/g added 
amount of CA (─); pH ~6 and I = 0.01 M. 
 
FTIR-ATR is an adequate surface analysis tool to identify surface bonds; however, it is very 
important to guarantee that the coating molecules do not interact with the ATR crystal surface itself. 
For example, on zinc selenide (ZnSe) crystal, citric acid is capable of Zn2+ chelation [33] involving the 
carboxylates and hydroxyls the same way as in the formation of Fe-citrate complexes. We have 
applied the diamond ATR crystal to exclude the interaction of the carboxylic acids with the crystal 
surface. Our FTIR-ATR results confirmed that the high-affinity adsorption (a kind of chemical 
adsorption mechanism) of CA, GA and PAM on MNPs at pH ~6 and I = 0.01 is due to inner-sphere 
surface complex formation, while the non-high-affinity adsorption (a transition to non-specific 
physical adsorption mechanism) of PAA is owing to outer-sphere binding. Surface spectroscopy has 
made it clear that CA, GA and PAM are preferable for MNP coating, while PAA is not. 
2.2. Chemical Stability of the Core-Shell MNPs  
Chemical stability of the coated nanoparticles was tested in iron dissolution experiments by ICP 
determination of dissolved iron in the aqueous dispersions of carboxylate@MNPs in 0.01 M NaCl 
solution at pH ~6. As it is seen in Figure 3a, significant iron dissolution is detected in the presence of 
CA coating as compared to the other three carboxylate coatings. The maximum measured value of iron 
dissolution from CA@MNPs was 1.25 mg/g MNP. Rodríguez et al. [34] have found similar iron 
dissolution rate (~1.5 mg/g Fe3O4) at somewhat different experimental conditions: The specific surface 
area of their Fe3O4 was 26 m2/g (100 m2/g of our MNPs); the dispersion concentration was 0.15 g/L 
(10 g/L in our experiments); the concentration of CA was 67 mmol/g Fe3O4 (0.257 mmol/g MNP in 
our experiments). The above data reflect the known effect of particle size on solubility (Ostwald 
ripening phenomenon [35]). The smaller the particle size in the colloidal range, the larger the surface 
curvature and surface free energy are, which in turn promote particle dissolution. It follows that similar 
degree of iron dissolution can also be achieved at much lower CA concentrations from nanoparticles 
than from micron-sized particles (0.257 and 67 mmol/g, respectively). We should note that citric acid 
is also capable of reductive dissolution of iron oxide [36–40], and this corrosion further enhances the 
rate of nanoparticle decomposition. The latter effect is larger for the higher-surface-area nanoparticles. 
In contrast to the effect of CA, PAA addition increased iron dissolution only to a small degree (slightly 
above the detection limit of the experiment): The amount of ~0.035 mg Fe/g MNP is two orders of 
magnitude smaller than that for CA coating. In the case of GA and PAM coatings, the dissolved iron 
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concentration remained below the detection limit even at the highest added amounts of the 
carboxylates meaning that the latter coatings passivized the magnetic core of MNPs. 
Figure 3. (a) Dissolved iron concentration in carboxylate@MNP dispersions (10 g/L in 
0.01 M NaCl solution at pH ~6) in the function of the amount of added carboxylates, CA, 
GA, PAA and PAM. The lines are drawn to CA and PAA data to guide the eyes. The error 
bars are omitted for the sake of clarity. The dotted line indicates the iron detection limit; 
(b) Specific magnetization curves measured in the dispersions of CA and PAA coated 
MNPs (100 g/L in water at pH ~6) at different added amounts of the carboxylates. 
 
In addition, magnetization curves of the CA@MNP and PAA@MNP dispersions were measured to 
test the effect of iron dissolution on the core size and magnetization of the MNPs. The results are 
shown in Figure 3b for some samples. Because iron dissolution leads to the decrease in particle size 
and the value of saturation magnetization (MS) depends on the size of the magnetic core [41–45], the 
saturation magnetization values are in turn sensitive to iron dissolution (for MNPs from the same lot). 
As it is seen in Figure 3b, only CA could induce considerable decrease in the MS value. PAA coating 
(0.8 and 1.6 mmol COOH/g MNP) as well as the lower amounts of CA (0.45 and 0.9 mmol COOH/g 
MNP) did not alter appreciably the specific magnetization, measured as 53–58 emu/g for all of them. 
Further increase in the added amount of CA to 1.6 mmol COOH/g MNP lowered the saturation 
magnetization to MS ~42 emu/g. The latter value corresponds to the magnetic core size of ~5.58 nm as 
calculated by using the equation for particle size dependence of MS [44] known as the “law of 
approach to saturation”. Haddad and co-workers [43] arrived at similar results by measuring core sizes 
and magnetization curves in parallel; the diameters of their MNP samples were ~5.5 and ~8.3 nm and 
the corresponding MS values ~38 and ~50 emu/g, respectively. We calculated from the iron dissolution 
experiments (Figure 3a) that addition of CA at 1.6 mmol COOH/g MNP concentration reduced the 
particle size to ~7.2 nm from the original 8 nm (Experimental Section). At ~1.6 mmol COOH/g CA 
addition the extrapolated value of Fe dissolution is ~30 mg Fe/g and the loss of Fe3O4 is ~42 mg/g. For 
particle size calculation we used the value of magnetite density, ρ = 5.046 g/cm3 [46]. Due to the effect 
of surface spin disorder [45,47], the size of the magnetic mass of MNPs is ~2 nm smaller than the 
physical particle size (a ~1 nm thick interfacial layer of the particles has an altered magnetic moment 
or cannot be magnetized at all); thus, the size of the effective magnetic core is ~5.2 nm. This result is 
close to the above values of 5.58 nm (calculated for ~42 emu/g using the “law of approach to 
saturation”) and 5.5 nm (at ~38 emu/g measured by Haddad et al. [43]). 
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The results of the iron dissolution supported by magnetization studies show clearly that the CA 
coated MNPs are not stable chemically. Although the high-affinity adsorption (Figure 1a) and the 
formation of inner-sphere surface Fe-carboxylate complexes (FTIR-ATR results) imply long-time 
residence of CA in the coating layer of MNP, we have proven that in parallel with CA adsorption, 
significant particle degradation/corrosion occurs as well. The presence of dissolved iron in the solution 
phase of the CA@MNP dispersions as either Fe-citrate complexes or iron hydrolysis products is 
unacceptable for biomedical applications. Soenen and co-workers [28,29,48] studied the extent of iron 
dissolution from citrate-, dextran-, carboxydextran-, and lipid-coated MNPs (VSOP C200, Resovist, 
Endorem, and magnetoliposomes, respectively) in cellular media in vitro and found that the  
citrate-coated VSOP degrades most rapidly and magnetoliposomes possess the highest chemical 
stability. A range of adverse effects on cell functionality was observed. In addition, MNP degradation 
inhibited their use for magnetic imaging or targeting at the concentrations not yet toxic for cells, 
because the magnetic response decreased with decreasing magnetic core size. Their findings underline 
the absolute necessity of efficient passivation of the MNPs by the coating shell for biomedical 
application. Our dissolution experiments show that passivation of the PAA-coated nanoparticles is also 
insufficient, since iron was dissolved to some degree. At the same time, the magnetization 
measurements reveal that deterioration of particles affects the value of saturation magnetization only at 
high levels of dissolution, but not at lower. The loss of Fe3O4 from CA@MNP at 1.6 mmol COOH/g 
MNP is ~4.2%, while it is not measurable for the PAA-coated MNPs. Thus, the adsorption and iron 
dissolution tests disqualify CA and PAA and only GA and PAM remain as applicable in biomedical 
carboxylate@MNP formulations. 
2.3. Colloidal Stability of the Core-Shell MNPs 
The measurements of electrokinetic potential and hydrodynamic diameter of core-shell MNPs are 
extremely helpful in optimizing the loading of coating molecules (at the given pH and ionic strength, 
see Section 2.1.1.), and assessing the salt tolerance of the composites at physiological pH (e.g., pH ~7 
in the blood). The results are published entirely for PAA and PAM coatings in [23] and [24]. In this 
paper, we complete the previous partial discussions on CA coating [22,25,26] and compare the 
characteristic points of all four carboxylated MNPs. 
The change in the particle charge due to CA adsorption measured as electrokinetic potential (ζ)  
of MNP is shown in Figure 4 in parallel with the adsorption data. From the combined 
adsorption/electrokinetic potential plots, a more detailed picture of adsorption mechanisms can be 
deduced, which in turn can be used to support the findings of the adsorption and chemical stability 
studies as well. The same combined plots for PAA and PAM systems are shown in the previous 
publications [23,24]. Three characteristic COOH concentration values can be identified in Figure 4, 
also given in Table 1 for all carboxylates. The high-affinity adsorption limit can be defined very 
precisely with the help of the f(x) = x line drawn to the adsorbed amount vs. added amount data points. 
The f(x) = x line represents practically complete adsorption of the added COOH groups. Adsorption 
data start to deviate from this line approximately at the high-affinity adsorption limits 0.33, 0.17 and 
0.38 mmol COOH/g MNP for CA, GA and PAM, respectively. For PAA adsorption (with  
non-high-affinity adsorption isotherm), the data points lie below the f(x) = x line in the whole range. 
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The isoelectric point (IEP, the zero value of electrokinetic potential; here the surface charge 
neutralization point due to adsorption of oppositely charged ions) is found well within the range of 
high-affinity adsorption for GA and PAM (at 0.05 and 0.17 mmol COOH/g MNP, respectively), but 
far beyond that for CA (at 0.45 mmol COOH/g MNP). In high-affinity adsorption, the specific 
interactions overcome electrostatic repulsion. This explains the continuation of adsorption beyond IEP 
regardless of the like-charge character both of carboxylate ions and of the carboxylated surface. In the 
CA@MNP system, however, the IEP is not reached at the high-affinity limit, but only at a significantly 
higher carboxylate concentration. It is clear that not only the adsorption of CA proceeds. The excess 
amount of COOH above its adsorbed amount is most likely consumed in iron dissolution, as discussed 
above. The complete overcharging of the MNPs due to carboxylate coverage (ζ ~ (−40) mV) can be 
seen in the electrokinetic potential plots at around 0.4 mmol COOH/g MNP for all three (GA, PAA 
and PAM) carboxylates that did not (or only weakly) dissolve iron oxide. However, in the case of CA 
coating, the advanced dissolution of MNPs increases the characteristic value of complete overcharging 
to twice the amount for other carboxylates (~0.8 mmol COOH/g MNP). 
Figure 4. Plots of the electrokinetic potential of CA@MNPs (---) and the adsorbed amount 
of COOH groups at the MNP surface (─) as a function of COOH addition to MNP 
dispersion at pH ~6.5 and I = 0.01 M. The error bars are omitted for the sake of clarity. The 
lines are drawn to guide the eyes, except for f(x) = x. 
 
Table 1. The amounts of added COOH groups needed to reach characteristic conditions 
(i.e., high-affinity adsorption limit, IEP and overcharging) in the carboxylate@MNP 
dispersions at pH ~6.5 and I = 0.01 M. 
Characteristic points 
CA GA PAA PAM 
mmol COOH/g MNP 
High-affinity adsorption limit 0.33 0.17 - 0.32 
Isoelectric point (charge neutralization) 0.45 0.05 0.13 0.17 
Complete overcharging ~0.8 0.4 0.4 0.4 
The pH-dependence of electrokinetic potential and hydrodynamic diameter values of the coated 
MNPs at different citrate loadings is shown in Figure 5. With increasing CA amount, the IEP shifts to 
lower pH values, and the pH range of highly negatively charged CA@MNPs becomes gradually 
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broader (Figure 5a) similarly to that experienced in all other carboxylic acid formulations [23–26]. 
Despite their high negative electrokinetic potential at pH >5, all the CA@MNP samples (except for  
the highest CA loading of 1.95 mmol COOH/g MNP) undergo aggregation (Figure 5b). The 
aggregation at high electrokinetic potential values can be caused by dissolved ferric ions or  
iron-citrate complexes. 
Figure 5. pH-dependent electrokinetic potential (a) and particle diameter (b) of magnetite 
nanoparticles at citric acid (CA) loadings of 0, 0.48, 0.57, 0.975 and 1.95 mmol/g. The 
error bars are omitted for the sake of clarity. The lines are drawn to guide the eyes. 
 
(a) (b) 
The salt tolerance of the CA@MNP formulations was determined in coagulation kinetics 
experiments at the highest CA contents, since only these dispersions were sufficiently stable in 0.01M 
NaCl at near physiological pH ~6.5. It is seen in Figure 6a that the hydrodynamic size of the naked 
MNPs increased with time already in the presence of 1 mM NaCl, while the CA-coated particles 
(Figure 6b) were fairly stable even at 10 mM NaCl. Significant increase in the particle size of 
CA@MNPs with time was observed at 80 mM NaCl and above. The plots of the stability constant (W) 
versus NaCl concentration (Figure 7) allow determining the critical coagulation concentration (CCC) 
values as ~1 mM for naked MNPs and ~70 mM for CA@MNPs (both for the 1.9 and 3.0 mmol 
COOH/g MNP samples). The conclusion of these experiments is that CA@MNPs do not stand 
physiological salt concentration in a simple physicochemical experiment. There are indications in 
literature that CA@MNPs are also unstable in biological media. For example, Safi et al. [49] tested the 
aggregation kinetics of citrate-coated γ-Fe2O3 particles in phosphate buffer (PBS) and a cell culture 
medium (RPMI), and found that the particles underwent rapid coagulation. In addition, the 
precipitating particles interacted strongly with human lymphoblastoid cells, and a massive and rapid 
adsorption of iron oxide on the cell surfaces was observed. 
The salt tolerance of the carboxylated MNPs increases in the following order:  
GA (~20 mM) < CA (~70 mM) < PAA (~500 mM) = PAM (~500 mM) as given previously [25,26]. It 
has also been observed that GA adsorption is able to stabilize the MNPs to the same degree as PAA 
and PAM when it is allowed to polymerize in the adsorbed layer for longer time. The detailed 
discussion of the preparation and characterization of GA@MNPs will be the subject of a forthcoming 
publication. GA-coated MNPs do not qualify for in vitro and in vivo experiments according to the 
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colloidal stability tests, albeit their performance is outstanding in both adsorption and chemical 
stability experiments. In conclusion, from the four studied MNPs, only the PAM@MNP is appropriate 
for further biological testing processes. The present study provides important messages that (i) the 
surface modifying property of a specific functional group depends greatly on the chemical structure of 
its host molecule; and (ii) in a consequent physicochemical pre-selection procedure, the biologically 
adequate core-shell MNPs can be chosen from the whole series of similar candidates. We emphasize 
that our optimization and selection procedure concerns core-shell formulations based on the 
physicochemical adsorption of small and large molecular carboxylates on naked iron oxide 
nanoparticles. Nevertheless, the basic principles discussed here can be adapted in other formulation 
methods as well. 
Figure 6. Time dependent increase in the particle size of (a) naked; and (b) citrate-coated 
MNPs measured at pH ~6.5 and different NaCl concentrations. 
(a) (b) 
Figure 7. Determination of the CCC values for naked and citrate-coated MNPs at pH ~6.5. 
The added amounts of CA are 1.95 and 3.0 mmol COOH/g MNP.  
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2.4. In Vitro and in Vivo Performance of Carboxylate@MNPs  
We have performed in vitro and in vivo experiments with the carboxylate@MNPs to test the 
usefulness and necessity of our selection procedure in identifying physicochemically appropriate 
nanoparticle formulations. Supposed that the results are consistent with those of cell and animal 
experiments, this procedure can be used to exclude inadequate formulations from the expensive and 
time consuming biological testing procedure and clinical trials. 
2.4.1. Biocompatibility Tests 
All of the CA, GA, PAA and PAM coated nanoparticles have been found nontoxic according to the 
previous MTT assays [23,24,26]; the viability of both healthy and cancerous cells in their presence 
decreased by less than 25%, the commonly accepted threshold of cytotoxicity. However, only 
PAM@MNP is fully adequate for biomedical testing according to the physicochemical tests. This 
leads to the conclusion that the small differences in the results of the MTT assays should be regarded 
as signs that differentiate nontoxic nanoparticles from those that are indeed bioapplicable. The latter 
should remain stable enough in biological media in order to perform their designed function. For 
example, dissolution of biocompatible core-shell MNPs leads to considerable reduction in saturation 
magnetization and to weak performance in MRI or magnetic hyperthermia applications [29,48]. The cell 
inhibition percentage values of the four carboxylated MNPs have been averaged over all types of cells 
tested and over all concentrations of MNPs (1, 5, 20, and 100 mg/L for CA, GA, PAA, and PAM).  
The results are shown in Table 2. The cell proliferation inhibition of CA and PAA coated MNPs is 
significantly higher than that of the GA and PAM coated MNPs in direct correlation with the results of 
the physicochemical tests. The cell inhibition percentage correlates with the iron-releasing property 
(dissolved iron), but does not correlate with the colloidal stability of the particles (CCC), meaning that iron 
dissolution is more important in the aspect of cell viability than nanoparticle aggregation. 
Table 2. Correlation between the averaged results of MTT assays [23,24,26] and the results 
of physicochemical measurements (iron dissolution and coagulation kinetics experiments). 
Carboxylate coating Averaged inhibition % Dissolved iron mg/g MNP CCC mM 
CA 18.3 ± 1.7 1.276 70 
GA 1.5 ± 0.5 0 20 
PAA 12.5 ± 1.4 0.038 500 
PAM 1.5 ± 0.5 0 500 
We have examined the erythrocyte sedimentation rate (ESR) of whole blood samples in the 
presence of CA, GA and PAA coated MNPs added at 0.16 mg/L concentration (Figure 8). Our 
previous study of the concentration-dependence of ESR in the presence of PAM@MNPs [24] showed 
no effect of the nanoparticles even at the highest added amount (0.16 mg/L). The same was observed 
in the present experiments for all the other nanoparticles. It is seen in Figure 8 that the height of 
sediments was the same both in the presence and absence of the MNPs. 
This result could be somewhat surprising in the light of the above discussed variations in  
the chemical and colloidal stability and nontoxicity level of all particles. It is likely that the protein 
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corona [50,51] adsorbed form the serum can protect them from aggregation. This effect is reflected in the 
fact that MNP aggregation cannot be seen even in the supernatants of the sedimentation experiments. 
Figure 8. Blood sedimentation experiment: Blood sample of Donor #3 with CA@MNP 
(CA), GA@MNP (GA) and PAA@MNP (PAA) added at 0.16 mg/mL concentration, in 
comparison with the control sample (C). 
 
We could test the iron dissolution effect of citrate in biological media by performing smear 
experiments on two series of whole blood samples, one collected in EDTA and the other in Na-citrate 
coated vacutainer tubes. We have observed thrombocyte aggregation in blood samples with GA or 
PAA-coated MNPs from citrate-anticoagulated blood, but there were no aggregates in the  
EDTA-anticoagulated ones (Figure 9). As thrombocyte aggregation is controlled by a very wide 
variety of biological factors [52], it is difficult to explain why it occurs in citrate-anticoagulated, but 
not in EDTA-anti-coagulated blood. One of the possible explanations is directly connected with the 
general observation that surface charge (and surface potential) lowering is always observed in platelet 
aggregation [53–55]. In the presence of high citrate concentration in the vacutainers (CA/MNP is  
0.16 mol/mg) the dissolved Fe-citrate complex can become adsorbed on the platelet surface and 
decrease the surface potential, while EDTA-chelation prevents iron adsorption. In addition, EDTA 
itself is known to increase platelet surface charge [55]. According to another observation, 
thrombocytes can aggregate in the smears from non-anticoagulated blood because of mechanical 
stress, while EDTA protects thrombocytes from aggregation [56]. In our experiments, however, 
citrate-anticoagulated control samples without MNPs did not show the signs of thrombocyte 
aggregation. It is apparent that the displacement of the coating shells of MNPs by the large amount of 
citrate causes iron dissolution and thrombocyte aggregation. 
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Figure 9. Pictures of the blood smears prepared from (a) EDTA-anticoagulated blood with 
GA@MNP; (b) EDTA-anticoagulated blood with PAA@MNP; (c) Citrate-anticoagulated 
blood with GA@MNP; and (d) Citrate-anticoagulated blood with PAA@MNP. 
 
2.4.2. Chemical Stability of Carboxylate@MNPs in Biological Media 
We have chosen the CA, PAA, and PAM-coated MNPs to test iron dissolution in biological media. 
In vitro experiments were performed in HeLa cell cultures prepared the same way as in the MTT tests. 
Prussian blue staining was applied after the second day of growing to visualize the distribution of iron. 
It is seen in Figure 10 that stained iron is localized in high concentration near the HeLa cells and the 
light blue colored background indicates the presence of iron at very low concentration. In the case of 
CA@MNPs (Figure 10b) the extended light blue colored areas spread across the intercellular space in 
a diffuse manner, indicating iron leaching from the MNPs. Iron leaching is less significant in the 
PAA@MNP (Figure 10c) and practically absent in the PAM@MNP (Figure 10d) incubated cell 
cultures; the contour of the blue-stained spots becomes increasingly sharper from CA to PAA to PAM 
coating. These somewhat subjective, but significant observations correlate with the iron dissolution results 
of the physicochemical experiments and support that only PAM@MNPs are efficiently passivized. 
Figure 10. Prussian blue staining of HeLa cells (a) incubated with 14.7 mg/mL 
concentration dispersions of CA@MNP (b); PAA@MNP (c); and PAM@MNP (d). 
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In in vivo experiments, the CA@MNP and PAA@MNP dispersions were injected intravenously in 
rat tails. The iron leaching feature was observed (Figure 11), similarly to that in cell cultures. The veins 
apparently crashed upon injection and the majority of nanoparticles spread into the tissues around the 
veins. However, nanoparticles have also been transported by the vascular system; blue-stained particles 
are present in the arteries (white areas surrounded by the array of wall cells) as well. 
Figure 11. Prussian blue staining of rat tail tissues with IV injected carboxylate@MNP 
particles: (a) CA@MNP at 20x; and (b) PAA@MNP at 20x magnification; (c) and (d) are 
the 40× magnification of the selected areas of (a) and (b). 
 
The light blue colored hazy background of low iron concentration is spilled into the intercellular 
space much more diffusely and extensively in the CA@MNP injected tissue than in the PAA@MNP 
treated one. At the present state of studies, it cannot be known, whether Prussian blue staining reflects 
the presence of dissolved iron in the form of citrate (or biomolecular) complexes indeed. Similar 
pictures are frequently seen in literature [57–61], but the main concern in general is the iron-positivity 
and not the exact form of the iron. On the other hand, the above observations closely correlate with the 
iron dissolution results in simple aqueous media and so, iron dissolution in the biological media is also 
probable. In addition, in vivo iron dissolution from citrate-coated nanoparticles is found by other 
authors as well [28,29]. 
2.4.3. Cellular Uptake of Carboxylate@MNPs 
We have incubated the HeLa cell cultures with CA, PAA and PAM-coated nanoparticles at low 
concentration, namely, half of that in iron dissolution tests (Figure 10), for tracking cell internalization 
of MNPs. The latter is seen as accumulation of MNPs within the cells around the nucleus. The cellular 
interactions of these MNPs were significantly different: CA@MNPs were both internalized and 
adsorbed (Figure 12b), while PAA@MNPs preferably internalized (Figure 12c) and PAM@MNP 
mainly adsorbed on the cell surface (Figure 12d). 
This finding is very important. It supports one of the conclusions from physicochemical 
characterizations that despite all the MNPs are covered with carboxylated shell; their fate in  
the cellular environment can be very much different depending on the chemistry of carboxylates and 
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the compactness of shell. It is known that negatively charged nanoparticles are prone to  
cell internalization [21], which is evidently not the case after 48 h incubation in our tests with 
PAM@MNPs and CA@MNPs. 
Figure 12. Prussian blue staining of HeLa cells (a) incubated with 7.35 mg/mL 
concentration dispersions of CA@MNP (b); PAA@MNP (c); and PAM@MNP (d). 
 
3. Experimental Section 
3.1. Materials 
Magnetite (Fe3O4) nanoparticles (MNPs) were synthesized from the mixture of FeCl2 and FeCl3 
salts, according to the alkaline hydrolysis method [62–65]. The size of the resulting particles was 
determined based on transmission electron microscopic pictures as d ~8–10 nm (d is the mean particle 
diameter). Citric acid (CA), gallic acid (GA), poly(acrylic acid) (PAA, Mw = 1800 Da) and 
poly(acrylic acid-co-maleic acid) (PAM, Mw = 3000 Da, 50 wt. % in H2O) were purchased from 
Sigma-Aldrich. The concentrations of the carboxylic acids are expressed through the molar amount of 
carboxylic groups. In the case of PAA and PAM the carboxyls in the monomeric units are taken into 
account: –COOH/Mw,AA = 1/72 = 0.0139 mol/g and –COOH/Mw,AM = 3/188 = 0.0159 mol/g, i.e., 1 g of 
PAA (or PAM) contains 0.0139 (or 0.0159) mol COOH. The pH and ionic strength were set by 
solutions of NaCl, HCl and NaOH, analytical grade products of Molar (Hungary). Milli-Q water was 
used. All experiments were performed at room temperature (25 ± 1 °C). 
TEM micrographs of the naked and the CA-, GA-, PAA- and PAM-coated MNPs, taken using a 
Philips CM-10 transmission electron microscope supplied with a Megaview-II camera, are presented in 
Figure 13a. The accelerating voltage was 100 kV and the maximum resolution of the instrument is  
0.2 nm. The particles were deposited on Formwar-coated copper grids from highly diluted suspensions 
and the samples were dried under infrared light. The size distribution (Figure 13b) was 9.7 ± 1.0,  
10.5 ± 1.4, 9.4 ± 0.8, 10.1 ± 0.9 and 10.8 ± 1.2 nm for the naked MNP, CA@MNP, GA@MNP, 
PAA@MNP and PAM@MNP, respectively, as determined by evaluating 100 particles using the 
UTHSCSA Image Tool 2.00 software. 
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Figure 13. Transmission electron micrographs of the MNP, CA@MNP, GA@MNP, 
PAA@MNP and PAM@MNP samples (a); and their size distribution (b). 
 
HRTEM pictures and XRD spectra of the naked MNPs have been published [66] and showed a 
crystalline structure with well resolved magnetite diffraction peaks. 
3.2. Methods 
The adsorption and desorption isotherms of the polyacids were determined by batch method at  
pH = 6.5 ± 0.5 (denoted in the text as pH ~6.5) and constant ionic strength, 0.01 M (set by NaCl). 
Magnetite suspensions were equilibrated with the series of polyacid solutions in closed test tubes for 
24 h at room temperature. The suspension concentrations were 1–20 g/L and the highest polyacid 
concentration was 10 mmol/L. The pH was adjusted by NaOH or HCl solution, and checked at the end 
of the adsorption time. The equilibrium concentrations of GA, PAA and PAM were determined 
spectrophotometrically in a USB4000 spectrometer (Ocean Optics, Dunedin, FL, USA) and those of 
CA by cerimetric titration using ferroin indicator. The absorbance of the supernatants at 260 nm (GA) 
or the difference in the absorbances at 223 and 250 nm (both PAA and PAM) were determined after 
perfect separation of the solid particles by centrifuging at 13,000 RPM for one hour. At higher 
polyacid concentrations, the separation was assisted by a permanent magnet and membrane filtration 
(0.22 μm MILLEX-GP). The iron concentration was determined in the supernatants of selected 
samples along the adsorption isotherms: four of them evenly distributed in the rising part and two of 
them in the plateau region. The iron content was measured in an Agilent 7700x ICP-MS spectrometer. 
Three parallel determinations were performed for each sample, and the measurement error was  
±25 µg/L. Below the threshold of ~200 ppb, reliable Fe concentration cannot be determined. The 
separated sediments were next redispersed in carboxylate solutions for measuring desorption 
isotherms. The concentration of the carboxylates was half of that in the adsorption. The equilibrium 
concentration was determined as in the adsorption experiments. The value of SD(n–1) = 0.12 was 
calculated for the adsorption and desorption experiments. 
FTIR-ATR spectra were recorded with a Bio-Rad Digilab Division FTS-65A/896 spectrometer 
(with DTGS detector), using a Harrick’s Meridian Split Pea Diamond ATR accessory. The absorbance 
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of the samples was measured in single reflection mode in the 400–4000 cm−1 frequency range with 
resolution of 2 cm−1, accumulating 256 scans. Magnetite suspensions, polyacid solutions or 
suspensions of the polyacid-coated MNPs were dried on the crystal surface. 
Electrophoretic mobilities of the pure (naked) and the polyacid-coated magnetite samples were 
measured in a NanoZS (Malvern, UK) apparatus at 25 ± 0.1 °C, in disposable zeta cells (DTS 1060). 
The settings of the instrument were checked by using a standard latex sample, the zeta potential of 
which is reported as ~(55 ± 5) mV by Malvern. The optimal scattering condition (~105 counts per 
seconds) was set by either 0.05 or 0.1 g/L magnetite concentration depending on the aggregation state 
of the dispersions. The pH was changed between ~3 and ~10 keeping the added amount of polyacids 
(per one gram of MNP) constant, or alternatively, the added amount of polyacids was varied at pH ~6. 
The ionic strength was constant: 0.005 M (CA) and 0.01 M (GA, PAA and PAM). The measurements 
were started after one hour equilibration time followed by an ultrasonic agitation for 10 s. The standard 
deviation of measured data was SD(n − 1) = 1. 
The hydrodynamic diameter of the particles was measured in a NanoZS apparatus (Malvern, UK) 
with a He-Ne laser (λ = 633 nm), operating in backscattering mode at an angle of 173°. The stock sols 
of magnetite particles were diluted with NaCl electrolyte to 0.1 g/L solid content. The ionic strength 
was constant as in the electrokinetic potential measurements and pH was adjusted in the range of 3 to 10, 
directly before the measurements. Before all measurements, the samples were homogenized by 
ultrasound agitation for 10 s and allowed to relax for 110 s. The average values of the hydrodynamic 
diameter (Zaverage) were calculated from the 3rd order cumulant fits of the correlation functions. The 
values of standard deviation of Zaverage varied between 15 (for the primary particles) and 150 (for 
aggregates of the size of ~1500 nm). 
Salt tolerance of the carboxylate@MNPs was tested in coagulation kinetics experiments at pH ~6.5 
by using a Zetasizer 4 (Malvern, UK) apparatus. The MNP concentration was set to 0.0025 g/L in 
order to achieve the optimum of light scattering and particle diffusion, and the aggregation was 
followed by detecting the evolution of the particle size (Zaverage) up to 600 s. The coagulation rate was 
calculated from the slope of the kinetic curves. The stability ratio (W) was calculated from the initial 
slopes of kinetic curves belonging to the slow and fast coagulation ranges. The critical coagulation 
concentration (CCC) was determined from the log10W vs. log10CNaCl (NaCl concentration) function. 
The standard deviation of the values of W was SD(n − 1) = 0.2. 
The magnetization curves were measured in a vibrating sample magnetometer VSM 880 
(DMS/ADE Technologies-USA) at the NCESCF-UP Timisoara. The analysis was performed on the 
carboxylate@MNP dispersions at ~10% by weight up to 10000 Oe as the maximum of the applied field. 
The values of specific magnetization were calculated for the exact amount of pure MNP in the samples. 
The interaction of CA, PAA and PAM coated MNPs with HeLa cells isolated from human cervix 
adenocarcinoma (ECACC, Salisbury, UK) was evaluated by the Prussian blue staining method. The 
cells were cultivated in minimal essential medium supplemented with 10% fetal bovine serum, 1% 
non-essential amino acids and an antibiotic-antimycotic mixture. All media and supplements were 
obtained from PAA Laboratories GmbH (Pasching, Austria). Near-confluent cancer cells were seeded 
onto a 96-well micro-plate at the density of 5000 cells/well. After an overnight standing, a 200 µL 
aliquot of the above medium containing the carboxylate@MNPs at 14.7 and 7.35 mg/mL 
concentration was added. After incubation for 48 h at 37 °C in humidified air containing 5% CO2, 
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ferric ion content of the cells was visualized by Prussian blue staining. The medium was removed and 
a 1:1 mixture of 2% potassium ferrocyanide and 2% hydrochloric acid was added for 10 min. Then the 
wells were washed with phosphate-buffered saline and the cells were photographed by means of a 
Nikon Eclipse microscope equipped with a QCapture CCD camera. 
Blood sedimentation in the presence of carboxylate@MNPs was tested in erythrocyte sedimentation 
rate (ESR) experiments, using a Sedi-15 automated blood sedimentation instrument (BD Inc., Franklin 
Lakes, NJ, USA) and Seditainer 1.8 vacutainer tubes (BD Inc., USA). The CA, GA or PAA coated 
particles (with carboxylate concentrations of 0.21, 0.61 and 1.02 mmol/g MNP, respectively) were added 
to citrate-anticoagulated whole blood of three healthy volunteers at a concentration of 0.16 mg/L. The 
ESR values were determined after 25 min standing and the accuracy of the measurements was ±3 mm/h. 
Blood smears were prepared by an automated slide preparation system (Sysmex SP4000i) using the 
May-Grünwald Giemsa (MGG, Biolyon, Dardilly, France) staining technique. For analysis of the 
smears an automated CellaVisionTM DM96 device (Cellavision AB, Ideon, Science Park, Lund, 
Sweden) was used, comprising a slide feeder unit, a microscope with ×10, ×50, and ×100 objectives, a 
digital camera, a computer, and an acquisition and classification software. The software classifies 
captured cells into 12 leukocyte categories, 6 RBC categories (normal and abnormal), aggregated 
thrombocytes, artifacts and smudged cells. GA@MNP and PAA@MNP dispersions were added to the 
citrate- and the EDTA-anticoagulated whole blood samples of Donor #3 at a concentration of 0.16 mg/L, 
as above. The samples were homogenized, allowed to stand at room temperature for 10 min, and 
homogenized again prior to smear preparation. 
In vivo testing of the carboxylated MNPs was performed by IV injection of 100 µL of the MNP 
dispersions into the tails of 6 Wistar rats. The dispersions were prepared at a concentration of  
10 mg/mL carboxylate@MNPs (using the optimal stabilizing amounts of the carboxylates) in physiological 
salt solution. Tissue samples were taken for examination at 1 h after the injection and stored in 
formaldehyde overnight. For optical microscopy, the tissue segments were embedded in paraffin and 
stained with combined Hematoxylin and Eosin. Prussian blue staining was used for iron detection. 
4. Conclusions 
We have shown that a designed physicochemical testing of magnetite core-shell nanoparticles for 
biomedical applications is an effective tool to exclude a priori inadequate formulations from in vitro 
and in vivo tests. The selection procedure should comprise (1) qualitative and quantitative 
characterization of shell formation on magnetic core (isotherm measurement); (2) determination of 
interaction strength between coating molecules and MNP surface; (3) quantitative optimization  
of coating to stabilize MNPs efficiently; (4) characterization of core-passivizing efficiency;  
(5) determination of particle charge (electrokinetic potential measurements); and (6) salt tolerance 
measurement of core-shell MNPs. The previously published PAA, PAM and GA-coated MNPs have 
been chosen to demonstrate the selection process. Its validity has been shown through a series of new 
experiments for CA-coated MNP as well. Although citric acid is a very popular coating molecule, 
CA@MNPs become entirely disqualified in the course of our selection procedure. This can explain to 
some extent the failure of such types of formulations in clinical trials, official (FDA, EMA or 
equivalent) approval or production/marketing to date.  
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For the sake of easy overview, we presented the scheme in Figure 14 that we have applied in the 
specific case of core-shell magnetite nanoparticles preparation based on adsorption of small and 
macromolecular carboxylates. The sequence of the experiments is important, since the basic properties 
such as the efficiency of core-shell fastening (strength of interaction), compactness of shell 
(passivizing efficiency), etc., determine the final behavior of the nano-composites and only the 
particles with the best coating quality should be tested for colloidal stability. In addition, all 
physicochemical tests must precede the in vitro and in vivo experiments to prove that the minimum 
criteria of biological applicability (i.e., the chemical and colloidal stability of the formulations at 
biological pH and NaCl concentrations) are fulfilled. 
It is known from the literature that protein corona formation can in principle hinder aggregation in 
physiological media, even if the colloidal stability tests predict aggregation. Thus, the next step in the 
testing of MNPs should be the in vitro study of protein adsorption. However, the coating shell of the 
particles with the highest colloidal stability may provide a better anchoring space for proteins in 
comparison with loosely packed shells. The importance of the chemical stability of the core-shell 
MNPs cannot be overestimated. It is highly advisable that chemically labile MNPs (with measurable 
corrosion or dissolution) are not allowed for in vitro experiments. We have experienced the obvious 
dissolution of iron from CA@MNPs and PAA@MNPs in optical imaging of cell cultures and the other 
in vitro and in vivo tests such as blood smears and tissue sections, while there was no sign of it in MTT 
tests. Iron dissolution enhances the toxicity of carboxylate@MNPs through oxidative stress and lowers 
the magnetic response because of a decrease in the magnetic core size. 
Figure 14. Schematic presentation of the suggested optimization procedure of 
carboxylate@MNP core-shell nanoparticles developed for biomedical applications; the 
route of preparation is the adsorption of the carboxylates to the naked MNPs. 
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